Table 4.
Association between histopathologic findings and gene expression profiles (from logistic regression analysis). Data are listed in ascending odds ratio (OR) values for each histopathologic finding. Only associations with CI not overlapping with 1 and P < 0.05 are shown.
Pathologic traits | Gene signature | OR | 95% CI | P |
---|---|---|---|---|
Size >5 cm | Boyault_G3 [25] | 3.93 | 1.03–15.00 | 0.045 |
Lee_Poor survival [49] | 4.86 | 1.21–19.47 | 0.026 | |
Chiang_Proliferation [22] | 5.06 | 1.20–21.42 | 0.028 | |
Villanueva_KRT19 [6] | 6.43 | 1.51–27.45 | 0.012 | |
Andersen_KRT19 [27] | 8.25 | 1.90–35.91 | 0.005 | |
Coulouarn_TGF beta [28] | 8.25 | 1.90–35.91 | 0.005 | |
Tumour grade (poorly differentiated) | Hoshida_S1 [12] | 4.50 | 1.04–19.39 | 0.044 |
Yamashita_EpCAM [48] | 4.50 | 1.04–19.39 | 0.044 | |
Boyault_G3 [25] | 4.71 | 1.18–18.86 | 0.028 | |
Lee_Poor survival [49] | 5.67 | 1.37–23.46 | 0.017 | |
Minguez_Vascular invasion [9] | 5.87 | 1.43–24.11 | 0.014 | |
Woo_Cholangiocarcinoma_like [26] | 5.87 | 1.43–24.11 | 0.014 | |
Andersen_KRT19 [27] | 9.90 | 2.18–44.98 | 0.003 | |
Coulouarn_TGF beta [28] | 9.90 | 2.18–44.98 | 0.003 | |
Hoshida_S1/S2 [12] | 10.20 | 2.26–46.09 | 0.003 | |
Chiang_Proliferation [22] | 10.56 | 2.17–51.42 | 0.004 | |
Villanueva_KRT19 [6] | 13.93 | 2.78–69.88 | 0.001 | |
Cairo_Hepatoblastoma [47] | 16.33 | 1.75–152.80 | 0.014 | |
Novak_Met [50] | 21.00 | 2.25–195.79 | 0.008 |